Savant Capital’s Qiagen QGEN Stock Holding History

Savant Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,460	Closed	-$291K	–	1560
2025 Q4	$291K	Buy	6,460 +297	+5%	+$13.7K	﹤0.01%	1069
2025 Q3	$275K	Sell	6,163 -1,672	-21%	-$80K	﹤0.01%	1073
2025 Q2	$377K	Buy	+7,835	New	+$341K	﹤0.01%	862

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Savant Capital's QGEN Position: Q1 2026 in Review

Savant Capital sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 6,460 shares — an estimated $291K sold.

Savant Capital first reported a position in QGEN in Q2 2025 and held it in 3 quarters. The position peaked at $377K in Q2 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Savant Capital reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
Savant Capital sold 6,460 Qiagen shares in Q1 2026, an estimated $291K.
Savant Capital first reported a position in Qiagen in Q2 2025 and held it in 3 quarters.
Savant Capital's Qiagen position peaked at $377K in Q2 2025.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.